Facebook
X
LinkedIn
Forward
Bispecific Antibodies 2026: Updates in Hematologic Malignancies and Solid Tumors
Bispecific Antibodies 2026: Updates in Hematologic Malignancies and Solid Tumors
This regional, half-day CME conference will deliver timely 2026 updates on the expanding use of bispecific antibody therapy in multiple myeloma, B-cell lymphomas, and select solid tumors. With a strong focus on real-world implementation, clinical leaders from cancer centers across Texas and nationally will share practical strategies for integrating these therapies into community cancer programs. The program will also offer opportunities for participants to engage directly with expert faculty and connect with regional healthcare professionals.
| Designation | Early Bird Deadline: April 16, 2026 | General Deadline: May 16, 2026 |
|---|---|---|
| Physicians (MD/DO) | $35 | $50 |
| Allied Health (NP, PA, RN, PharmD) | $20 | $35 |
| Industry Pharma/Med Device Company Employees** | $300 | $315 |
| Students & Fellows* | Free | |
REFUND POLICY
Cancellation Policy: Fees are non-refundable and non-transferable.
**Defined as anyone employed by a drug, device, or diagnostic company. We allow Industry Professionals to register for our conferences unless you are employed in a sales role with your company. Please note that we will accept a limited number of Industry Professionals (excluding sales) to each conference.
*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact [email protected] for further information.
Horizon CME will NOT provide international travelers with an invitation letter to attend this in-person activity. If you reside outside the United States or Canada and register and pay for this event, AND you are unable to obtain a visa to attend, no refund will be issued.
Privacy Statement: For online registration, we take precautions to protect your information. Sensitive information submitted via the website is protected both online and offline and used only to contact you regarding your registration.
Intended Learners
We designed this conference for a multidisciplinary audience, including primary care providers, gynecologists, surgeons, pulmonologists, gastroenterologists, medical and radiation oncologists, and other healthcare professionals managing cancer patients.
Presented By
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Central Standard Time Zone
| Saturday, May 16, 2026 | |
|---|---|
| 7:00am | Check-In & Breakfast Available in Exhibit Hall |
| 7:50am | Horizon CME App Overview |
| 7:55am | Welcome, Introductions, & CME/CE Housekeeping |
| 8:00am | Welcome from Dr. Rios |
| 8:15am | (01) What is a Bispecific Antibody? » Fateeha Furqan, MD, MBBS - Oncologist | MD Anderson Cancer Center | Houston, TX |
| 8:30am | (02) Bispecific Antibodies in Multiple Myeloma » Samer Al Hadidi, MD, MS (CRDSA), FACP - Associate Professor | Clinical Director of Amyloidosis Program | Harold C Simmons Comprehensive Cancer Center | Dallas, TX |
| 9:15am | Information About the Cancer Charities & Trivia For Charity Break |
| 9:20am | Break - Trivia for Charity in the Exhibit Hall |
| 9:45am | (03) Bispecific Antibodies in B-Cell Lymphomas » Sameh Gaballa, MD - Associate Member | Moffitt Cancer Center | Tampa, FL |
| 10:30am | (04) Bispecific Antibodies in Solid Tumors » TBA |
| 11:15am | (05) Roundtable Discussion #1 & Audience Q+A » Moderator: Luis Campos, MD - President | Oncology Consultants | Houston, TX |
| 11:30am | Gather for Lunch |
| 11:35am | Buffet Lunch & Non-CME/CE Presentation Sponsored by TBA » TBA |
| 12:20pm | (06) Integration of Bispecific Antibody Administration into Community Oncology Programs: Tricks of the Trade » Tara Graff, DO - Director of Clinical Research | Mission Cancer + Blood | Des Moines, IA |
| 1:05pm | Roundtable Discussion #2 & Audience Q+A » Moderator: Sara Taveras Alam, MD - Assistant Professor | UT Health Houston and Memorial Hermann Cancer Center | Houston, TX |
| 1:35pm | Networking + Dessert Reception |
We want to ensure that your time at the Bispecific Antibodies 2026: Updates in Hematologic Malignancies and Solid Tumors conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.
Overnight Accommodations:
Dates for discounted rates: May 15-16, 2026
Discounted Booking Deadline: April 23, 2026
Click here to book your room today!
Room rate: $199/night
Parking: Overnight parking $29
Disclaimer
All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.
Available Credit
- 5.50 ABIM Medical KnowledgeHorizon CME, Inc. designates this activity for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 5.50 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Live activity for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.50 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 5.50 credit.
- 0.50 Pharmacology
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 0.50 credit.